A200 AN INTEGRATED ANALYSIS OF EFFICACY OF OBETICHOLIC ACID IN CANADIAN PATIENTS

BACKGROUND: Obeticholic acid (OCA) is a potent FXR agonist investigated for the treatment of primary biliary cholangitis (PBC) in 3 randomized, double-blind (DB), placebo (PBO)-controlled trials ± UDCA. AIMS: This analysis pools data from all 3 trials to investigate the efficacy and safety of OCA in...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Can Assoc Gastroenterol
Hlavní autoři: Mason, A, Vincent, C, Aspinall, A, Swain, M, Hirschfield, G M, Minuk, G, Shah, H, Owens-Grillo, J, Malecha, E Smoot, MacConell, L
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2018
Témata:
Poster Presentations
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6507574/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy008.201
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky